155 related articles for article (PubMed ID: 38137405)
1. Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study.
Magnussen LV; Helskov Jørgensen L; Glintborg D; Andersen MS
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137405
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
4. MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial.
Magnussen LV; Andersen PE; Diaz A; Ostojic J; Højlund K; Hougaard DM; Christensen AN; Nielsen TL; Andersen M
Eur J Endocrinol; 2017 Aug; 177(2):157-168. PubMed ID: 28522646
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
[TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
[TBL] [Abstract][Full Text] [Related]
7. Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.
Pedersen L; Christensen LL; Pedersen SM; Andersen M
J Endocrinol Invest; 2017 May; 40(5):529-538. PubMed ID: 28000180
[TBL] [Abstract][Full Text] [Related]
8. Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial.
Christensen LL; Poulsen HE; Andersen MS; Glintborg D
Andrology; 2024 Jan; 12(1):115-122. PubMed ID: 37177884
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial.
Jensen RC; Christensen LL; Nielsen J; Schrøder HD; Kvorning T; Gejl K; Højlund K; Glintborg D; Andersen M
Andrology; 2018 Jul; 6(4):547-555. PubMed ID: 29656500
[TBL] [Abstract][Full Text] [Related]
10. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body composition.
Glintborg D; Christensen LL; Kvorning T; Larsen R; Højlund K; Brixen K; Hougaard DM; Handberg A; Andersen M
Scand J Clin Lab Invest; 2015; 75(8):659-66. PubMed ID: 26264425
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety.
Asih PR; Wahjoepramono EJ; Aniwiyanti V; Wijaya LK; de Ruyck K; Taddei K; Fuller SJ; Sohrabi H; Dhaliwal SS; Verdile G; Carruthers M; Martins RN
CNS Neurol Disord Drug Targets; 2015; 14(5):576-86. PubMed ID: 25921747
[TBL] [Abstract][Full Text] [Related]
16. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.
Skinner JW; Otzel DM; Bowser A; Nargi D; Agarwal S; Peterson MD; Zou B; Borst SE; Yarrow JF
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):465-481. PubMed ID: 29542875
[TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study.
Bøgehave M; Glintborg D; Gram JB; Bladbjerg EM; Andersen MS; Sidelmann JJ
Endocr Connect; 2023 Apr; 12(4):. PubMed ID: 36752832
[TBL] [Abstract][Full Text] [Related]
18. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups.
Ramachandran S; Hackett GI; Strange RC
Andrology; 2020 Sep; 8(5):1222-1232. PubMed ID: 32384175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
